What is an insulin inhaler?
Insulin inhaler is a healthcare facility that allows diabetic patients to receive doses of insulin inhalation. This can eliminate the need for insulin shots, potentially facilitate diabetes management. The first insulin inhaler was approved in 2006 and pulled out of the market less than two years later due to the anemic acceptance of the general public, but several pharmaceutical companies have not been introduced by the originally freezing attachment for inhalation insulin inhaler and undertaken to improve facilities that could only be success. Method of delivery of hormone: injection. Oral insulin was not effective because it would be distributed in the stomach before the body would absorb it, and the absorption efficiency of the membrane of the mouth and nose was too low to make viable methods of delivery. In the 90s there were several designs of bandage inhaler of insulin.
The idea of inhalation insulin is that the medicine can be transmitted to the lungs where it dissolves during the gas exchange process and quickly passes into the CRIn which occurs in the lungs. This ensures a quick division into the body. With some improvements, insulin inhaler was developed, which allowed patients to inhale medication, and inhaled hormone performed comparable to injection insulin in clinical trials.
The advantage of using insulin inhaler is that it eliminates the need for needles. This can facilitate and safer treatment of diabetes, as patients no longer need sandblasses and do not have to observe careful injections. However, some patients did not like inhalers because of their size; Injecting insulin would be less disturbing than the inhaler wrap. Some patients also felt uncomfortable with the delivery method.
changes in the world of medical devices often encounter poor initial recipes because patients are used to the methods they use. In the case of insulin therapy, injections have already been used80 years, which caused many patients not to trust the new delivery system, especially because many alternatives to injection were explored and eventually rejected between 20 and 2000. Since 2010, insulin inhale research has been focused on the development of smaller and lighter devices that would be easier to bear, and at the patient's reach to get used to the idea of inhalation insulin.